Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
Cash to Debt 0.01
HEPI's Cash to Debt is ranked lower than
57% of the 810 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.19 vs. HEPI: 0.01 )
HEPI' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.01

F-Score: 4
Z-Score: -40.81
M-Score: -12.66
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
ROA (%) -70.32
HEPI's ROA (%) is ranked lower than
54% of the 814 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 4.13 vs. HEPI: -70.32 )
HEPI' s 10-Year ROA (%) Range
Min: -12250.79   Max: -338.59
Current: -70.32

-12250.79
-338.59
ROC (Joel Greenblatt) (%) -3871.90
HEPI's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 810 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 16.57 vs. HEPI: -3871.90 )
HEPI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -37411.76   Max: -798.68
Current: -3871.9

-37411.76
-798.68
EPS Growth (%) 4.00
HEPI's EPS Growth (%) is ranked higher than
73% of the 626 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 4.00 vs. HEPI: 4.00 )
HEPI' s 10-Year EPS Growth (%) Range
Min: 0   Max: 448.5
Current: 4

0
448.5
» HEPI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HEPI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
EV-to-EBIT -5.70
HEPI's EV-to-EBIT is ranked higher than
50% of the 836 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 32.26 vs. HEPI: -5.70 )
HEPI' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -5.7

Current Ratio 0.01
HEPI's Current Ratio is ranked lower than
57% of the 809 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 2.28 vs. HEPI: 0.01 )
HEPI' s 10-Year Current Ratio Range
Min: 0.01   Max: 0.95
Current: 0.01

0.01
0.95
Quick Ratio 0.01
HEPI's Quick Ratio is ranked lower than
57% of the 809 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 1.75 vs. HEPI: 0.01 )
HEPI' s 10-Year Quick Ratio Range
Min: 0.01   Max: 0.93
Current: 0.01

0.01
0.93

Valuation & Return

vs
industry
vs
history
Forward Rate of Return (Yacktman) -18.48
HEPI's Forward Rate of Return (Yacktman) is ranked higher than
54% of the 682 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 3.19 vs. HEPI: -18.48 )
HEPI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0   Max: 0
Current: -18.48

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Specialty & Generic
Compare:TKPYY, AGN, FRX, MRX, ESALF » details
Health Enhancement Products, Inc., was incorporated under the laws of the State of Nevada on March 28, 1983 under the name of L. Peck Enterprises, Inc. On May 27, 1999 it changed its name to Western Glory Hole, Inc. on October 30, 2003, the Company acquired the outstanding shares of Health Enhancement Corporation and in connection with this transaction it changed its name to Health Enhancement Product, Inc. The Company is a health & wellness company engaged in the research and development of natural products derived from algae cultures for use as dietary supplements and food ingredients. These natural products are extracted from living algae grown in purified water.
» More Articles for HEPI

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... Oct 16 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Other Events Oct 14 2014
Presentation Schedule Now Available for RedChip's October 15-16 Global Online CEO Conference Oct 06 2014
Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting Sep 18 2014
HEALTH ENHANCEMENT PRODUCTS INC Financials Aug 23 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10-Q, Quarterly Report Aug 14 2014
Health Enhancement Products, Inc. Secures Capital Increase To Fund Ongoing Bovine And Canine Studies... Jul 17 2014
New Research Yields Promising Results for Supporting Canine Joint Health, Points to Dietary... Jun 30 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10-Q, Quarterly Report May 14 2014
Health Enhancement Products, Inc. Reveals Results From Canine Joint Health Study Conducted by... May 05 2014
Health Enhancement Products Announces Commencement of Bovine Mastitis Testing With Contract Research... Apr 24 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Other Events Apr 21 2014
Health Enhancement Products, Inc.'s President's Annual Report to Shareholders Mar 31 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Other Events Mar 31 2014
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 10-K, Annual Report Mar 31 2014
Health Enhancement Products Announces Start of Canine Joint Health Testing and Phase Two Synthetic... Mar 17 2014
Health Enhancement Products, Inc. Study at the University of Missouri Indicates Positive Results for... Feb 03 2014
Health Enhancement Products, Inc. Enters Into Collaborative Agreement With Global Animal Health... Dec 26 2013
HEALTH ENHANCEMENT PRODUCTS INC Files SEC form 8-K, Financial Statements and Exhibits Dec 23 2013
Health Enhancement Products, Inc. Expands Corporate Website, Launches Wellness Testing Subsidiary... Dec 03 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK